Likitanci da magunguna · Bayanan hukuma
EMA ta amince da Ruxolitinib Krka don cutar myelofibrosis da polycythaemia vera
Kwamitin EMA na Kayan Magani don Amfani da Mutane ya amince da kyakkyawan ra'ayi a ranar 12 ga Nuwamba, 2026, yana ba da shawarar izinin tallace-tallace don Ruxolitinib Krka. Wannan magani na gama-gari daga KRKA an tsara shi ne don magance cutar myelofibrosis da polycythaemia vera, wanda ke fadada zabin magani a EU.
Asalin tushe
Karanta tushen — ema.europa.eu ↗Muna haɗawa da ainihin mai wallafawa. Taƙaitawar da ke sama jagora ce kawai; karanta asalin don cikakken bayani.